Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Seeding in Cesarean-delivered Neonates
NCT03298334Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2018
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in childhood obesity and Immune-Mediated Inflammatory Disease (IMID) (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Adiposity at 2 years. Started Jul 2018; status: recruiting.
02
Conditions
childhood obesityImmune-Mediated Inflammatory Disease (IMID)
Beyond the preview
Go deeper on NCT03298334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03298334.